Quick Takeaways
- FEDERATED HERMES, INC. filed SCHEDULE 13G/A for Forte Biosciences, Inc. COMMON STOCK (FBRX).
- Disclosed ownership: 13%.
- Date of event: 30 Sep 2025.
Quoteable Key Fact
"FEDERATED HERMES, INC. disclosed 13% ownership in Forte Biosciences, Inc. COMMON STOCK (FBRX) on 30 Sep 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Federated Hermes, Inc. | 13% | 1,635,380 | 1,635,380 | 0 | /s/J. Christopher Donahue | J. Christopher Donahue, as President of Federated Hermes, Inc. | |
| Voting Shares Irrevocable Trust | 13% | 1,635,380 | 1,635,380 | 0 | /s/Thomas R. Donahue | Thomas R. Donahue, as Trustee of Voting Shares Irrevocable Trust | |
| Thomas R. Donahue | 13% | 1,635,380 | 0 | 1,635,380 | /s/Thomas R. Donahue | Thomas R. Donahue | |
| Ann C. Donahue | 13% | 1,635,380 | 0 | 1,635,380 | /s/Ann C. Donahue | Ann C. Donahue | |
| J. Christopher Donahue | 13% | 1,635,380 | 0 | 1,635,380 | /s/J. Christopher Donahue | J. Christopher Donahue |